Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy

A disease outbreak in December 2019, caused by a novel coronavirus SARS-CoV-2, was named COVID-19. SARS-CoV-2 infects cells from the upper and lower respiratory tract system and is transmitted by inhalation or contact with infected droplets. Common clinical symptoms include fatigue, fever, and cough...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskandarian Boroujeni, Mahdi, Sekrecka, Agata, Antonczyk, Aleksandra, Hassani, Sanaz, Sekrecki, Michal, Nowicka, Hanna, Lopacinska, Natalia, Olya, Arta, Kluzek, Katarzyna, Wesoly, Joanna, Bluyssen, Hans A. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156796/
https://www.ncbi.nlm.nih.gov/pubmed/35663932
http://dx.doi.org/10.3389/fimmu.2022.888897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156796/
https://www.ncbi.nlm.nih.gov/pubmed/35663932
http://dx.doi.org/10.3389/fimmu.2022.888897

Ejemplares similares